U.S. market Closed. Opens in 1 day 5 hours 52 minutes

JAZZ | Jazz Pharmaceuticals plc Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for JAZZ we got that it has average fundamentals where Valuation is considered to be undervalued, Profitability is poor, Growth is good and Health is weak.

Valuation (79%)

Company Industry
P/E Ratio (TTM) 16.31 -15.27
PEG Ratio (TTM) 0.86 -4.35
P/S Ratio (TTM) 1.86 45.97
P/B Ratio (TTM) 1.81 28.96
P/FCF Ratio (TTM) 6.58 -2.59
Price to 5YR AVG Earnings Ratio 55.27 -5.56
Price to 5YR AVG FCF Ratio 10.08 -12.33

Profitability (45%)

Company Industry
ROA (TTM) 3.78% -19.06%
ROE (TTM) 12.06% 15.70%
Net Profit Margin (TTM) 11.60% -813.88%
ROIC 5YR AVG 7.40% 3.12%

Growth (65%)

4QTR AVG 3YR AVG 5YR AVG
EPS 286.40% -86.19% 16.52%
Revenue 2.45% 18.19% 15.52%
Net Income 282.33% -91.74% 10.68%
Cash Flow 14.63% -0.14% 9.77%

Health (46%)

Company Industry
Current Ratio (TTM) 4.26 5.56
Quick Ratio (TTM) 3.74 5.34
D/E Ratio (TTM) 1.47 0.95
Interest Coverage (TTM) 2.67 -6.44
Piotroski F-Score 6 5
Altman Z-Score 1.49 12.45
LTL to 5YR AVG FCF 7.00 0.11
Shares Outstanding Growth 5YR AVG 1.18% 37.46%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙